ABL1 and Increased total eosinophil count: Clonality, as displayed by clonal cytogenetic and/or somatic mutation(s), must be present, but not the BCR-ABL1 translocation or other genetic abnormalities of myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusion [3].